2023
N-Indolyl diiron vinyliminium complexes exhibit antiproliferative effects in cancer cells associated with disruption of mitochondrial homeostasis, ROS scavenging, and antioxidant activity
BRESCIANI, Giulio, Jakub ČERVINKA, Hana KOSTRHUNOVÁ, Lorenzo BIANCALANA, Marco BORTOLUZZI et. al.Základní údaje
Originální název
N-Indolyl diiron vinyliminium complexes exhibit antiproliferative effects in cancer cells associated with disruption of mitochondrial homeostasis, ROS scavenging, and antioxidant activity
Autoři
BRESCIANI, Giulio (380 Itálie), Jakub ČERVINKA (203 Česká republika, domácí), Hana KOSTRHUNOVÁ (203 Česká republika), Lorenzo BIANCALANA (380 Itálie), Marco BORTOLUZZI (380 Itálie), Guido PAMPALONI (380 Itálie), Vojtěch NOVOHRADSKÝ (203 Česká republika), Viktor BRABEC (203 Česká republika), Fabio MARCHETTI (380 Itálie) a Jana KAŠPÁRKOVÁ (203 Česká republika)
Vydání
Chemico-Biological Interactions, Elsevier B.V, 2023, 0009-2797
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
10608 Biochemistry and molecular biology
Stát vydavatele
Irsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 5.100 v roce 2022
Kód RIV
RIV/00216224:14310/23:00132046
Organizační jednotka
Přírodovědecká fakulta
UT WoS
001094243700001
Klíčová slova anglicky
Diiron complexes; Indole; Anticancer; Mitochondria; ROS; Antioxidant
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 5. 12. 2023 11:30, Mgr. Marie Šípková, DiS.
Anotace
V originále
The indole scaffold has been established as a key organic moiety for developing new drugs; on the other hand, a range of diiron bis-cyclopentadienyl complexes have recently emerged for their promising anticancer potential. Here, we report the synthesis of novel diiron complexes with an indole-functionalized vinyliminium ligand (2–5) and an indole-lacking analogue for comparative purposes (6), which were characterized by analytical and spectroscopic techniques. Complexes 2–6 are substantially stable in DMSO‑d6 and DMEM-d solutions at 37 °C (8% average degradation after 48 h) and display a balanced hydrophilic/lipophilic behaviour (LogPow values in the range −0.32 to 0.47), associated with appreciable water solubility. The complexes display selective antiproliferative potency towards several cancer cells in monolayer cultures, mainly in the low micromolar range, with reduced toxicity towards noncancerous epithelial cells. Thus, the cytotoxicity of the complexes is comparable to or better than clinically used metallopharmaceutical cisplatin. Comparing the antiproliferative activity obtained for complexes containing different ligands, we confirmed the importance of the indolyl group in the mechanism of antiproliferative activity of these complexes. Cell-based mechanistic studies suggest that the investigated diiron vinyliminium complexes (DVCs) show cytostatic rather than cytotoxic effects and subsequently induce a population of cells to undergo apoptosis. Furthermore, the molecular mechanism of action involves interactions with mitochondrial DNA and proteins, the reactive oxygen species (ROS)-scavenging properties and antioxidant activity of these complexes in cancer cells. This study highlights the importance of DVCs to their cancer cell activity and reinforces their prospective therapeutic potential as anticancer agents.